MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Bioline RX Ltd Company Profile (NASDAQ:BLRX)

Consensus Ratings for Bioline RX Ltd (NASDAQ:BLRX) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $4.25 (338.14% upside)

Analysts' Ratings History for Bioline RX Ltd (NASDAQ:BLRX)
Show:
DateFirmActionRatingPrice TargetActions
5/18/2016Roth CapitalReiterated RatingBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Maxim GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$3.50 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$3.50 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha